We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+0.28%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$35.8B
AUM Growth
+$1.5B
(+4.4%)
Cap. Flow
+$1.13B
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
1,455
New
69
Increased
612
Reduced
362
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$105M |
| 2 |
Analog Devices
ADI
|
+$93.7M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$93.4M |
| 4 |
Amazon
AMZN
|
+$90.1M |
| 5 |
UnitedHealth
UNH
|
+$84.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$338M |
| 2 |
Qualcomm
QCOM
|
+$110M |
| 3 |
Wells Fargo
WFC
|
+$109M |
| 4 |
Linde
LIN
|
+$86.6M |
| 5 |
Baidu
BIDU
|
+$68.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.42% |
| 2 | Healthcare | 15.85% |
| 3 | Financials | 11.31% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
1101
Tectonic Therapeutic
TECX
$644M
| $394K | ﹤0.01% |
5,917
| – | – |
|
|
OPTU
1102
Optimum Communications Inc
OPTU
$308M
| $393K | ﹤0.01% |
20,207
-67
| -0.3% | -$1.95K |
|
1103
ImmunityBio
IBRX
$7.96B
| $389K | ﹤0.01% |
41,000
| – | – |
|
|
GOOS
1104
Canada Goose Holdings
GOOS
$854M
| $388K | ﹤0.01% |
10,697
| – | – |
|
1105
KE Holdings
BEKE
$18.8B
| $386K | ﹤0.01% |
21,775
-51,610
| -70% | -$1.26M |
|
1106
Entegris
ENTG
$22.4B
| $386K | ﹤0.01% |
3,000
-2,000
| -40% | -$241K |
|
1107
California Resources
CRC
$4.79B
| $381K | ﹤0.01% |
+9,448
| New | +$309K |
|
|
EGRX
1108
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $379K | ﹤0.01% |
6,900
| – | – |
|
1109
HEICO Corp
HEI
$50.9B
| $375K | ﹤0.01% |
2,804
+61
| +2% | +$8.03K |
|
1110
Theravance Biopharma
TBPH
$876M
| $374K | ﹤0.01% |
51,250
| – | – |
|
1111
Nurix Therapeutics
NRIX
$2.66B
| $366K | ﹤0.01% |
12,400
| – | – |
|
|
AXON
1112
Axon Enterprise
AXON
$46.8B
| $364K | ﹤0.01% |
2,115
+461
| +28% | +$83.7K |
|
1113
Jackson Financial
JXN
$8.81B
| $364K | ﹤0.01% |
+14,326
| New | +$390K |
|
1114
Imperial Oil
IMO
$62.4B
| $358K | ﹤0.01% |
11,415
+571
| +5% | +$15.8K |
|
1115
Sana Biotechnology
SANA
$999M
| $358K | ﹤0.01% |
16,600
+15,000
| +938% | +$315K |
|
|
YMAB
1116
DELISTED
Y-mAbs Therapeutics
YMAB
| $355K | ﹤0.01% |
12,700
| – | – |
|
1117
AngloGold Ashanti
AU
$49.1B
| $354K | ﹤0.01% |
23,100
-5,000
| -18% | -$86.6K |
|
|
IMGN
1118
DELISTED
Immunogen Inc
IMGN
| $349K | ﹤0.01% |
62,000
| – | – |
|
1119
Schneider National
SNDR
$6.16B
| $342K | ﹤0.01% |
14,909
| – | – |
|
1120
BWX Technologies
BWXT
$15.7B
| $339K | ﹤0.01% |
6,300
-5,215
| -45% | -$294K |
|
|
RPTX
1121
DELISTED
Repare Therapeutics
RPTX
| $332K | ﹤0.01% |
12,900
| – | – |
|
1122
MacroGenics
MGNX
$260M
| $330K | ﹤0.01% |
16,200
| – | – |
|
1123
Sony
SONY
$140B
| $330K | ﹤0.01% |
14,850
+5,500
| +59% | +$115K |
|
1124
Teva Pharmaceuticals
TEVA
$42.5B
| $329K | ﹤0.01% |
33,804
+4,439
| +15% | +$41.6K |
|
|
RNAM
1125
DELISTED
Avidity Biosciences
RNAM
| $324K | ﹤0.01% |
14,000
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2021 Portfolio in Review
As of Q3 2021, DekaBank Deutsche Girozentrale held 1,455 positions worth $35.8B, up 4.4% from $34.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.13B of net new capital in Q3 2021, opening 69 new positions and adding to 612 existing holdings. Its largest new stake was Ambarella: 99,200 shares worth $15.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $110M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2021 buy was Ambarella: 99,200 shares worth $15.1M.
- DekaBank Deutsche Girozentrale added most to Stellantis in Q3 2021, an estimated $105M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2021 reduction was Qualcomm, cutting an estimated $110M.
- DekaBank Deutsche Girozentrale fully exited Deutsche Bank in Q3 2021, selling an estimated $338M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $35.8B portfolio in Q3 2021.
- DekaBank Deutsche Girozentrale opened 69 new positions and closed 87 in Q3 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 4.4% quarter-over-quarter to $35.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.